XML 39 R13.htm IDEA: XBRL DOCUMENT v3.19.1
DEFERRED COSTS
12 Months Ended
Dec. 31, 2018
Deferred Policy Acquisition Costs Disclosures [Abstract]  
Deferred Policy Acquisition Costs [Text Block]
NOTE 6 — DEFERRED COSTS
 
Effective January 1, 2018, the Company capitalizes initial and renewal sales commission payments in the period a customer contract is obtained, and payment is received; and is amortized consistent with the transfer of the goods or services to the customer over the expected period of benefit, which we have deemed to be the contract term.
 
Such commissions are amortized over the greater of contract term or technological obsolescence period when the underlying contracted products are technology-based, such as for the SaaS-based platforms, or the expected customer relationship period when the underlying contracted products are not technology-based, such as for patient experience survey products.
The table below summarizes the activity within the deferred commission costs account, during the year ended
December 31, 2018
:
 
 
 
January 1,
 
 
Commission
 
 
Commission
 
 
December 31,
 
 
 
2018
 
 
Costs Deferred
 
 
Amortized
 
 
2018
 
Deferred costs, short term
 
$
80,153
 
 
$
199,236
 
 
$
(103,383
)
 
$
176,006
 
Deferred costs, long term
 
 
-
 
 
 
93,790
 
 
 
-
 
 
 
93,790
 
Deferred commission costs
 
$
80,153
 
 
$
293,026
 
 
$
(103,383
)
 
$
269,796
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
During the year ended December 31, 2018, the Company deferred an aggregate $293,026 commissions paid and reclassified from equity $80,153 previously paid and expensed commissions. Amortization of deferred costs for the year ended December 31, 2018 was $103,383.